Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Shares Jump 8.8 Percent on Positive Research News

NEW YORK, Dec. 2 (GenomeWeb News) - Shares in Sequenom were up 8.8 percent at $.99 in mid-afternoon trading today after the company said that a major US university has used its genotyping technology to identify SNPs in E. coli.

The increase in share price, which was accompanied by heavy trading volume, represents the third straight day of gains for the San Diego-based high-throughput genotyping company. The stock has slid from a high of $4.50 in late January to around a dollar, where it has hovered since around mid-October.

 

If the stock closes below $1 today, it will mark 29 consecutive trading days that the shares have traded below the Nasdaq's minimum benchmark. Failing to trade for that minimum for 30 consecutive trading days would trigger a warning letter from the exchange, which could lead to Sequenom being delisted from the Nasdaq Nationl Market demoted to the Nasdaq SmallCap market.

 

Sequenom in September escaped receiving such a letter from the Nasdaq by a similar one-day margin.

The shares began their current climb in overnight trading yesterday after Sequenom said that the Universityof Californiaat San Diegohad used its flagship MassArray technology to conduct automated, high-throughput mutation-detection studies on E. coli.

The research, led by Bernhard Palsson, professor of bioengineering at UCSD, is published in the December issue of Genome Research.

Charles Cantor, Sequenom CSO, said that the research represents the first time that the company's MassArray platform has been used to conduct high throughput genetic analysis of bacteria, and provides a foundation for the development of large scale comparative sequencing processes using the technology.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.